MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Association analysis of the nutritional status and serum nutritional index in patients with Parkinson’s disease

    L. Chen, W. Chen, Q. Guo, L. Jiang, Y. Hu, Y. Liu, W. Xian (Guangzhou, China)

    Objective: This study was conducted to determine the associations between the nutritional status and serum nutritional index and motor symptoms among patients with Parkinson’s disease(PD).…
  • 2018 International Congress

    Ondansetron, a highly-selective 5-HT3 receptor antagonist, alleviates L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease

    C. Kwan, I. Frouni, D. Bédard, A. Hamadjida, P. Huot (Montreal, QC, Canada)

    Objective: To determine the effectiveness of selective serotonin 3 (5-HT3) receptor blockade at reducing the severity of established, and preventing the development of, dyskinesia. Background:…
  • 2018 International Congress

    Effects of JN403, an α-7-nicotine-acetylcholine-receptor (α7-nAChR) agonist on human alpha-synuclein-mediated in vitro and in vivo models of Parkinson’s disease

    B. Lee, C. Noelker, W. Chiu, D. Feuerbach, L. Timmerman, W. Oertel (Marburg, Germany)

    Objective: To investigate whether JN403, a novel selective agonist of α-7-nicotine-acetylcholine-receptors (α7-nAChRs) can suppress inflammation and toxicity in human alpha-synuclein (αSyn) induced in vitro and…
  • 2018 International Congress

    Influence of baseline OFF-time in the efficacy response of opicapone in Parkinson’s disease patients with motor fluctuations: The BIPARK-I double-blind experience

    P. Korlipara, J. Ferreira, H. Gama, A. Santos, F. Ikedo, E. Arbe, J-F. Rocha, P. Soares-da-Silva (London, United Kingdom)

    Objective: To evaluate the efficacy of opicapone (OPC) in levodopa-treated Parkinson’s Disease (PD) patients with motor fluctuations and subdivided by their baseline OFF-time. Background: OPC,…
  • 2018 International Congress

    A first-in-human clinical study to test the safety and preliminary efficacy of CDNF in Parkinson’s disease

    H. Huttunen, S. Booms, J. Koskinen, M. Saarma (Espoo, Finland)

    Objective: To develop a novel disease-modifying therapy in Parkinson's disease (PD) that affects both motor and non-motor symptoms, based on a novel stress-protective protein CDNF.…
  • 2018 International Congress

    Augmented Reality-Based Dance Application on Balance and Mobility of Individuals with Parkinson’s Disease: A Pilot Study

    T. Tunur, K. Rickford, A. DeBlois, E. Horton-Yates, L. Columna (San Marcos, CA, USA)

    Objective: To investigate the acute and long-term effects of a mobile, augmented reality-based extension of Dance for PD® classes on balance and mobility in persons…
  • 2018 International Congress

    Basal Ganglionic Lesions in Egyptian Children: Radiological Findings in Correlation with Etiology and Clinical Manifestations

    H. Zehry, S. Darwish, S. El zayat, H. Gad, H. Emam, M. (Mansoura, Egypt)

    Objective: to determine the etiology of basal ganglionic disorders in a sample of Egyptian children. Background: In childhood, the metabolic activity of the basal ganglia…
  • 2018 International Congress

    Exosomal alpha synuclein secretion is beneficial for cellular models of Kufor-Rakeb syndrome

    T. Tsunemi, Y. Ishiguro, A. Yoroisaka, W. Akamatsu, D. Krainc, N. Hattori (Tokyo, Japan)

    Objective: The purpose of this study is to investigate the effect of induction of exosomal a-syn secretion on PARK9-mediated neurotoxicity. Background: Kufor-Rakeb syndrome (KRS) is…
  • 2018 International Congress

    Biological course and natural history of hereditary spastic paraplegia type 11 (SPG11)

    T. Musacchio, K. Nohl, K. Boelmans, V. Maltese, D. Zeller, I. Isaias, J. Volkmann, S. Klebe (Würzburg, Germany)

    Objective: We aim to establish biological markers for the natural history and course of hereditary spastic paraplegia (HSP) type 11 (SPG11) using multiple readout parameters…
  • 2018 International Congress

    Patient with secondary dystonia treated with internal globus pallidus deep brain stimulation (GPi-DBS), 2 years results: A case report

    O. Morsi, AE. Baidez, J. Jimenez, J. Lopez, G. Valero, B. Cuartero, M. Felipe, R. Carrasco, J. Zamarro (Murcia, Spain)

    Objective: To assess long term benefit of multiple source steering of GPi-DBS in a patient with secondary dystonia due to kernicterus related perinatal encephalopathy. Background:…
  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley